The effects of l- and d-stereoisomers of phenylisopropyl-adenosine (PIA) were tested on the central nervous and circulatory system. In mice l-PIA in doses of 0.1--0.2 mg/kg i.p. reduced motor activity and muscular coordination, prolonged barbiturate sleeping time and exerted a hypothermic and analgetic effect. In most of these tests even 10--20 times higher doses of d-PIA proved to be ineffective. In isolated guinea-pig heart preparation l-PIA increased the coronary flow, diminished the contraction amplitude and frequency in approximately 1/20 of the doses than did d-PIA. Blood pressure of rats was markedly lowered by l-PIA in doses of 6--15 mug/kg i.v. but not by the same dose of d-PIA. There seems to be stereospecificity for PIA in various tissues and animals in vivo as well as in isolated organs. The l-isomer is usually 10--20 times more active than the d-form. In addition to stereospecificity at receptor sites, differences in lipid solubility of the stereoisomers could explain these findings.
Download full-text PDF |
Source |
---|
Naunyn Schmiedebergs Arch Pharmacol
August 2024
Medical Faculty, Institute for Pharmacology and Toxicology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Cantharidin and sodium fluoride inhibit the activity of serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A) and increase the force of contraction in human atrial preparations. R-phenylisopropyl adenosine (R-PIA) acts as an agonist at A-adenosine receptors. R-PIA exerts a negative inotropic effect on human atria.
View Article and Find Full Text PDFKorean J Anesthesiol
October 2020
Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Background: Studies investigating the correlation between spinal adenosine A1 receptors and vincristine-induced peripheral neuropathy (VIPN) are limited. This study explored the role of intrathecal N6-(2-phenylisopropyl)-adenosine R-(-)isomer (R-PIA) in the rat model of VIPN.
Methods: Vincristine (100 μg/kg) was intraperitoneally administered for 10 days (two 5-day cycles with a 2-day pause) and VIPN was induced in rats.
Toxicology
January 2019
Institute of Toxicology, School of Public Health, Shandong University, 44 Wenhua West Road, Shandong Province, Jinan City, 250012, PR China. Electronic address:
Our previous study showed that both Kupffer cell eliminator (GdCl) and tumor necrosis factor α (TNF-α) receptor antagonist (etanercept) could partially attenuate binge drinking-induced liver steatosis. Herein, we extended the study by directly investigating the roles of TNF-α on the hepatic fat levels in mice and in HepG2 cells, and explored the underlying mechanisms. SPF male ICR mice were exposed to TNF-α (0.
View Article and Find Full Text PDFPharmacol Res
October 2013
CNR Clinical Physiology Institute, Pisa, Italy; University of Siena, Italy. Electronic address:
Adenosine (ADO) is a retaliatory metabolite that is expressed in conditions of injury or stress. During these conditions ATP is released at the extracellular level and is metabolized to adenosine. For this reason, adenosine is defined as a "danger signal" for cells and organs, in addition to its important role as homeostatic regulator.
View Article and Find Full Text PDFEpilepsy Behav
October 2011
Departamento de Neurologia e Neurocirurgia, Neurologia Experimental, Universidade Federal de São Paulo, São Paulo, Brazil.
Aiming at a better understanding of the role of A(2A) in temporal lobe epilepsy (TLE), we characterized the effects of the A(2A) antagonist SCH58261 (7-(2-phenylethyl)-5-amino-2(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine) on seizures and neuroprotection in the pilocarpine model. The effects of SCH58261 were further analyzed in combination with the A(1) agonist R-Pia (R(-)-N(6)-(2)-phenylisopropyl adenosine). Eight groups were studied: pilocarpine (Pilo), SCH+Pilo, R-Pia+Pilo, R-Pia+SCH+Pilo, Saline, SCH+Saline, R-Pia+Saline, and R-Pia+SCH+Saline.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!